Athena Countouriotis
CIK 1571469 · President & CEO · last filed 2026-06-04
Athena Countouriotis is a President & CEO who has filed 44 SEC Form 4 insider transactions across 8 companies since 2013. The most recent filing, for BMRN, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$7.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.29M
8
44
-$7.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMRN | Director | 21,040 | $55.95 | $1.18M | $0 | 4 | 2026-06-04 |
| PASG | Director | 18,900 | $5.81 | $109.8K | $309.9K | 9 | 2026-05-21 |
| IOVA | Director | — | $4.08 | — | $0 | 8 | 2025-06-17 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | President & CEO | 0 | $76.01 | $0 | -$7.44M | 8 | 2022-08-17 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | — | — | — | $0 | 2 | 2019-06-24 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | SVP, Chief Medical Officer | 150,000 | $4.36 | $654.0K | $0 | 2 | 2018-02-20 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP and Chief Medical Officer | 45,977 | — | — | $0 | 8 | 2017-02-24 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Chief Medical Officer | — | $0.54 | — | $0 | 3 | 2014-11-12 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | BMRN | Grant (A) | +7,490 | $0 | EDGAR |
| 2026-05-21 | PASG | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | PASG | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | BMRN | Grant (A) | +6,650 | $0 | EDGAR |
| 2024-06-13 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | BMRN | Grant (A) | +4,720 | $0 | EDGAR |
| 2024-05-23 | PASG | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2023-12-28 | BMRN | Grant (A) | +2,180 | $0 | EDGAR |